Back to UBS Group AG UBS Group AG

LEXXLEXX
17 quarters

Position history for UBS Group AGUBS Group AG's holdings in LEXARIA BIOSCIENCE CORP

Yes. Ubs holds 46,966 shares of LEXX (Lexaria Bioscience), worth $26,301, as of its Q2 2026 13F filing. It reduced the position by 5,742 shares (-10.9%) from Q1 2026. Ubs has held LEXX since Q2 2025, across 5 quarterly 13F filings.

Current Value

$26,301

Current Shares

46,966

Total Value Change

+$9,301

Total Shares Change

+42,832

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
46,966
-10.9%
$26,3010.0%$8.40
0
2026-Q1
Decreased
52,708
-85.4%
$41,1120.0%$11.70
0
2025-Q4
Increased
361,300
+4995.9%
$222,9230.0%$9.26
25
2025-Q3
Increased
7,090
+16.7%
$6,7570.0%$14.30
13
2025-Q2
New
6,074
-
$5,2840.0%$13.05
23
2025-Q1
Exited
0
-100.0%
$00.0%$25.65
0
2024-Q4
New
116
-
$2440.0%$31.50
17
2024-Q1
Exited
0
-100.0%
$00.0%$54.45
0
2023-Q4
New
4,532
-
$5,6650.0%$18.75
24
2023-Q3
Exited
0
-100.0%
$00.0%$15.00
0
2023-Q2
Decreased
99
-97.9%
$720.0%$10.95
0
2023-Q1
Decreased
4,639
-17.1%
$12,6180.0%$40.80
0
2022-Q4
Decreased
5,596
-12.5%
$13,7660.0%$36.90
0
2022-Q3
Increased
6,398
+53.4%
$16,0000.0%$36.75
17
2022-Q2
Increased
4,171
+56.6%
$12,0000.0%$44.70
17
2022-Q1
Decreased
2,663
-35.6%
$9,0000.0%$49.50
0
2021-Q4
New
4,134
-
$17,0000.0%$60.45
28

Other major holders of LEXX: GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used